GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Diamyd Medical AB (OSTO:DMYD B) » Definitions » Price-to-Tangible-Book

Diamyd Medical AB (OSTO:DMYD B) Price-to-Tangible-Book : 6.00 (As of Jun. 04, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Diamyd Medical AB Price-to-Tangible-Book?

As of today (2024-06-04), Diamyd Medical AB's share price is kr11.46. Diamyd Medical AB's Tangible Book per Share of Feb. 2024 for the quarter that ended in Feb. 2024 was kr1.91. Hence, Diamyd Medical AB's Price to Tangible Book Ratio of today is 6.00.

The historical rank and industry rank for Diamyd Medical AB's Price-to-Tangible-Book or its related term are showing as below:

OSTO:DMYD B' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.13   Med: 6.17   Max: 37.86
Current: 6

During the past 13 years, Diamyd Medical AB's highest Price to Tangible Book Ratio was 37.86. The lowest was 1.13. And the median was 6.17.

OSTO:DMYD B's Price-to-Tangible-Book is ranked worse than
76.99% of 1221 companies
in the Biotechnology industry
Industry Median: 2.81 vs OSTO:DMYD B: 6.00

A closely related ratio is called PB Ratio. As of today, Diamyd Medical AB's share price is kr11.46. Diamyd Medical AB's Book Value per Sharefor the quarter that ended in Feb. 2024 was kr1.91. Hence, Diamyd Medical AB's P/B Ratio of today is 6.00.


Diamyd Medical AB Price-to-Tangible-Book Historical Data

The historical data trend for Diamyd Medical AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamyd Medical AB Price-to-Tangible-Book Chart

Diamyd Medical AB Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.25 37.86 12.75 5.23 4.96

Diamyd Medical AB Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.87 4.86 4.96 3.18 7.72

Competitive Comparison of Diamyd Medical AB's Price-to-Tangible-Book

For the Biotechnology subindustry, Diamyd Medical AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diamyd Medical AB's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Diamyd Medical AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Diamyd Medical AB's Price-to-Tangible-Book falls into.



Diamyd Medical AB Price-to-Tangible-Book Calculation

Diamyd Medical AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Feb. 2024 )
=11.46/1.909
=6.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Diamyd Medical AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Diamyd Medical AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Diamyd Medical AB (OSTO:DMYD B) Business Description

Traded in Other Exchanges
Address
Kungsgatan 29, Stockholm, SWE, SE-111 56
Diamyd Medical AB is a Sweden-based company engaged in the field of pharmaceutical development. It develops therapies using in-licensed substances glutamic acid decarboxylase (GAD) and GABA for the prevention or treatment of diabetes and other inflammatory diseases. The firm is focused on finding the cure for diabetes and other serious inflammatory diseases through pharmaceutical development and investments in stem cells and medical technology. Its product portfolio consists of Diamyd, for the treatment of autoimmune diabetes; Remygen, a regenerative and immunomodulatory therapy for the treatment of autoimmune diabetes and type 2 and type 1 diabetes.

Diamyd Medical AB (OSTO:DMYD B) Headlines

No Headlines